Earnings Call · Q2 FY2024·2024-08-15

Q2 24EPS +42.86%·Rev n/aQ1 24EPS -40.52%·Rev n/aQ4 23EPS -60.53%·Rev n/aQ3 23EPS -2.67%·Rev n/a⚠ consensus missing

Vivos Therapeutics, Inc. VVOS

John Lee — Investor Relations or Conference Call Host

Brad Amman — Chief Financial Officer

Kirk Huntsman — Chairman and Chief Executive Officer

−5.1%1d on move date−6.8% vs SPY3d+9.7%5d+19.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VVOS calls or request research access.

More VVOS calls Browse calls Request research access